FF30 Table-top Filling and Capping Machine - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

FF30 Table-top Filling and Capping Machine


The Flexicon FF30 semi-automatic filling and capping machine is ideal for flexible small scale production. The speed of the FF30 can be adjusted to match the working speed of the operator and liquids can be filled in volumes from 0.1ml to 100ml with +/-0.5% accuracy.

Offering a capacity up to 1200 bottles per hour (depending on filling volume and operator), and able to handle bottles between 12mm and 50mm in diameter, key application areas for the FF30 include the diagnostic industry, hospital pharmacies, R&D departments, essential oil manufacturers, cosmetics producers and general subcontract filling/finish companies.

The FF30 ensures clean production without risk of cross-contamination; a consistent cap torque prevents any leakage of liquid, while a bottle/cap change takes a maximum of five minutes, helping improving uptime and productivity.

The machine’s small footprint makes it ideal for use in laminar air flow units or bio-safety cabinets.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race

Click here